ArticleSkeletal muscle2015

CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy.

Fernanda Pinto-Mariz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.